Streetbeat News

Stock Prices

FTHWF

MSSTF

REUN

Reunion Neuroscience (NASDAQ:REUN) is set to go private following a final court approval. The company is closing on its take-private transaction with MPM BioImpact affiliates, with shareholders approving the arrangement plan. The acquisition of Reunion in an all-cash transaction of $13.1 million is expected to close on or about July 21, 2023. Reunion was split from Field Trip Health in mid-2022 and has been developing a novel serotonergic psychedelic compound, RE104, as a potential treatment for postpartum depression.

Portfolio Pulse from Lara Goldstein

July 17, 2023 | 9:04 pm

AEON

Priveterra Acquisition has been authorized to list on the NYSE following its business combination with AEON Biopharma. Post-merger, AEON will be a wholly owned subsidiary of Priveterra, which will change its name to AEON Biopharma, Inc. Trading under the new ticker symbol 'AEON' is expected to begin on July 24, 2023.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 9:04 pm

UBER

Analysts have provided bullish ratings for Uber Technologies (NYSE:UBER) within the last quarter, with no bearish or indifferent ratings. The average price target is $54.72, implying an upside from the current price of $45.51. The average price target has increased by 7.29% over the past month.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 9:00 pm

PSFE

Paysafe Limited (NYSE:PSFE) announced a new partnership with micro-betting app Betr, allowing players in Ohio and Massachusetts to securely deposit funds into their account using a range of payment methods. The news led to a 4.41% increase in PSFE shares on Monday.

Portfolio Pulse from Ryan Gustafson

July 17, 2023 | 9:00 pm

KIND

Analysts have provided indifferent ratings for Nextdoor Holdings (NYSE:KIND) within the last quarter. According to 5 analysts offering 12-month price targets in the last 3 months, Nextdoor Holdings has an average price target of $2.97 with a high of $3.50 and a low of $2.40. This average price target has increased by 23.75% over the past month.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 9:00 pm

YELP

Over the past 3 months, 4 analysts have published their opinion on Yelp (NYSE:YELP) stock. The average price target is $35.5, implying a downside from the current price of $42.02. The average price target has increased by 3.41% over the past month.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 9:00 pm

COYA

Coya Therapeutics (NASDAQ:COYA) has received 8 bullish analyst ratings in the last quarter, with no bearish or indifferent ratings. The average 12-month price target for the company, according to these analysts, is $19.75, marking a 97.5% increase over the past month.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 9:00 pm

ABOS

Acumen Pharmaceuticals is planning a public offering of $100M of its common stock, with an option for underwriters to purchase an additional $15M. The proceeds will be used to fund the Phase 2 trial of ACU193, other R&D activities, and for working capital and other corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 8:55 pm

SPXY

UVXY

Convexity Daily 1.5x SPIKES Futures ETF (NYSE:SPXY) was trading about 1.5% lower on Monday, bouncing up slightly from near the $5 level. The ETF tracks the SPIKES Futures Short-Term Index and measures volatility in broad-based equities. The Federal Reserve’s next meeting on July 25 and 26 could increase stock market volatility, potentially sending SPXY higher. The ETF appears to have formed a bullish double-bottom pattern, indicating a potential bounce higher.

Portfolio Pulse from Melanie Schaffer

July 17, 2023 | 8:52 pm

ABOS

Acumen Pharmaceuticals is planning to file a preliminary prospectus supplement with the SEC for a proposed offering of common stock. As of June 30, 2023, the company had approximately $172.2M in cash and marketable securities.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 8:50 pm